Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes

Area of Science:

• Endocrinology
• Immunology
• Metabolic Diseases

Background:

• Type 1 diabetes management focuses on beta-cell preservation.
• Previous studies assessed C-peptide levels ~10 weeks post-diagnosis.
• The utility of earlier C-peptide assessments remains unclear.

Purpose of the Study:

• To determine if early C-peptide measurements predict long-term beta-cell function in type 1 diabetes.
• To identify clinical factors associated with C-peptide levels early after diagnosis.

Main Methods:

• Pooled data from a multi-center randomized trial.
• Assessed 90-minute mixed-meal tolerance test (MMTT) stimulated C-peptide at 2 and 6 weeks post-diagnosis.
• Correlated early C-peptide values with 1- and 2-year post-diagnosis C-peptide levels.

Main Results:

• C-peptide levels increased from baseline to 6 weeks post-diagnosis.
• Early C-peptide levels (2 and 6 weeks) strongly correlated with 1- and 2-year C-peptide concentrations (p < 0.001).
• Six-week C-peptide showed the highest correlation with 1- and 2-year values (r=0.66 and r=0.61).
• Older age, higher baseline, and 6-week C-peptide predicted higher long-term C-peptide levels.

Conclusions:

• C-peptide assessments shortly after diagnosis predict future C-peptide production.
• A plateau in C-peptide levels is observed around 6 weeks post-diagnosis.
• MMTT assessments earlier than 6 weeks do not improve prediction of residual beta-cell function.